Madeleine M Hipp

Affiliations
  • CureVac AG, Tübingen, Germany.

Publications (1)

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Journal for immunotherapy of cancer
Avec: Alexandros Papachristofilou , Madeleine M Hipp , Ute Klinkhardt , Martin Früh , Martin Sebastian , Christian Weiss , Miklos Pless , Richard Cathomas , Wolfgang Hilbe , Georg Pall , Thomas Wehler , Jürgen Alt , Helge Bischoff , Michael Geißler , Frank Griesinger , Karl-Josef Kallen , Mariola Fotin-Mleczek , Andreas Schröder , Birgit Scheel , Anke Muth , Tobias Seibel , Claudia Stosnach , Fatma Doener , Henoch S Hong , Sven D Koch , Ulrike Gnad-Vogt , Alfred Zippelius

Réseau de co-auteurs

Alexandros Papachristofilou 1 collaboration
Ute Klinkhardt 1 collaboration
Martin Früh 1 collaboration
Martin Sebastian 1 collaboration
Christian Weiss 1 collaboration
Miklos Pless 1 collaboration
Richard Cathomas 1 collaboration
Wolfgang Hilbe 1 collaboration
Georg Pall 1 collaboration
Thomas Wehler 1 collaboration
Jürgen Alt 1 collaboration
Helge Bischoff 1 collaboration
Michael Geißler 1 collaboration
Frank Griesinger 1 collaboration
Karl-Josef Kallen 1 collaboration
Mariola Fotin-Mleczek 1 collaboration
Andreas Schröder 1 collaboration
Birgit Scheel 1 collaboration
Anke Muth 1 collaboration
Tobias Seibel 1 collaboration
Claudia Stosnach 1 collaboration
Fatma Doener 1 collaboration
Henoch S Hong 1 collaboration
Sven D Koch 1 collaboration
Ulrike Gnad-Vogt 1 collaboration
Alfred Zippelius 1 collaboration